Rankings
▼
Calendar
NVCR Q1 2025 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena
NVCR
NovoCure Limited
$1B
Q1 2025 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$155M
+11.9% YoY
Gross Profit
$116M
75.1% margin
Operating Income
-$38M
-24.4% margin
Net Income
-$34M
-22.1% margin
EPS (Diluted)
$-0.31
QoQ Revenue Growth
-3.9%
Cash Flow
Operating Cash Flow
-$36M
Free Cash Flow
-$46M
Stock-Based Comp.
$30M
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$887M
Stockholders' Equity
$362M
Cash & Equivalents
$127M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$155M
$139M
+11.9%
Gross Profit
$116M
$105M
+11.1%
Operating Income
-$38M
-$42M
+8.8%
Net Income
-$34M
-$39M
+11.5%
Geographic Segments
UNITED STATES
$93M
47%
International Markets
$57M
29%
GERMANY
$19M
9%
FRANCE
$18M
9%
JAPAN
$9M
4%
CHINA
$5M
2%
← FY 2025
All Quarters
Q2 2025 →